Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

CUSIP: 09627Y109

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
65,000,000
Total 13F shares
25,884
Share change
-8,419
Total reported value
$2,574,129
Price per share
$114.22
Number of holders
2
Value change
-$1,079,310
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 09627Y109?
CUSIP 09627Y109 identifies BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2025

As of 31 Dec 2025, Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,884 shares. The largest 2 holders included DekaBank Deutsche Girozentrale and HUNTINGTON NATIONAL BANK. This page lists 2 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.